KARYOPHARM THERAPEUTICS INC (KPTI) Stock Balance Sheet
NASDAQ:KPTI • US48576U2050
Current stock price
5.57 USD
+0.36 (+6.91%)
At close:
5.44 USD
-0.13 (-2.33%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 60.54M | 62.48M | 52.23M | 135.20M | 190.50M | |||
| Marketable Securities | 3.20M | 46.24M | 139.21M | 142.80M | 38.20M | |||
| Receivables | 26.18M | 30.77M | 26.96M | 47.10M | 22.50M | |||
| Inventories | 4.04M | 4.74M | 3.04M | 4.20M | 4.10M | |||
| Other Current Assets | 9.19M | 12.28M | 12.47M | 20.90M | 20.30M | |||
| Total Current Assets | 103.15M | 156.49M | 233.92M | 350.20M | 275.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.65M | 6.28M | 4.88M | 7.40M | 9.60M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Assets | 618.00K | 1.64M | 1.64M | 600.00K | 20.10M | |||
| Total Non-Current Assets | 5.27M | 7.93M | 6.52M | 8.00M | 29.70M | |||
| TOTAL ASSETS | 108.42M | 164.42M | 240.44M | 358.20M | 305.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 21.01M | 24.43M | N/A | N/A | N/A | |||
| Accrued Expenses | 65.47M | 61.09M | 64.70M | 61.30M | 71.40M | |||
| Accounts Payable | 4.00M | 5.11M | 3.12M | 2.80M | 1.60M | |||
| Other Current Liabilities | 1.58M | 1.64M | 1.65M | 1.80M | 700.00K | |||
| Total Current Liabilities | 92.06M | 92.26M | 69.48M | 65.90M | 73.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 278.22M | 236.45M | 303.40M | 302.80M | 302.30M | |||
| Other Non-Current Liabilities | 31.06M | 21.72M | 3.77M | 6.10M | 9.00M | |||
| Total Non-Current Liabilities | 309.28M | 258.17M | 307.17M | 308.90M | 311.30M | |||
| TOTAL LIABILITIES | 401.34M | 350.44M | 376.64M | 374.80M | 385.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.76B | -1.56B | -1.49B | -1.34B | -1.18B | |||
| Additional Paid In Capital | 1.47B | 1.38B | 1.35B | 1.33B | 1.10B | |||
| Common Shares | 14.00K | 13.00K | 12.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 71.00K | -356.00K | -161.00K | -600.00K | 200.00K | |||
| Shares Outstanding | 18.31M | 8.41M | 7.66M | 7.55M | 5.05M | |||
| Tangible Book Value per Share | -16.00 | -22.11 | -17.78 | -0.15 | -1.05 | |||
| Total Shareholders' Equity | -292.93M | -186.02M | -136.21M | -16.70M | -79.70M | |||
| TOTAL LIABILITIES AND EQUITY | 108.42M | 164.42M | 240.44M | 358.20M | 305.30M | |||
| Statistics | ||||||||
| Debt/Equity | -0.95 | -1.27 | -2.23 | -18.13 | -3.79 | |||
| Current Ratio | 1.12 | 1.70 | 3.37 | 5.31 | 3.74 | |||
| Return On Assets (ROA) | -180.82% | -46.48% | -59.52% | -46.15% | -40.65% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21